The global generics and API manufacturing market is predicted to double by 2023 to $474billion, resulting in more and more companies who are looking to invest in generics and APIs. Newport, a Cortellis solution, is a target and analysis tool designed to help you assess the market and identify business opportunities in this industry. Join us for this webinar to discover how recent enhancements will improve your Newport experience.
In 40 minutes, you’ll learn how to:
- Create a shareable one-page Executive Summary on a drug or biologic making it easy for you and your colleagues to make quick decisions about a molecule.
- Run a newly created search that allows you to find the API manufacturers you need. Search by location, dose form and more.
- Quickly discover what PIV filings have been filed by your competitors.
- Export into a single, handy table all the Newport Constraint Date exclusivity information on a drug or biologic for all countries.